v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash Flows from Operating Activities      
Net income $ 3,563 $ 3,401 $ 2,556
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Depreciation, amortization and accretion, net (93) (159) (154)
Deferred income tax expense (benefit) 157 125 18
Share-based compensation 206 193 187
Net realized investment (gains) losses (3) 15 47
Net trading (gains) losses (6) (7) (9)
Loss from equity method investments 8 19 27
Impairments and provision for loan and credit losses 19 9 (16)
Net (gains) losses of consolidated investment entities 12 (13) 23
Changes in operating assets and liabilities      
Restricted and segregated investments 477 102 (8)
Deferred acquisition costs 52 36 64
Policyholder account balances, future policy benefits and claims, and market risk benefits, net 4,610 3,831 3,071
Derivatives, net of collateral (394) (1,696) (624)
Receivables (159) 215 276
Brokerage deposits (385) (55) (781)
Accounts payable and accrued expenses 261 105 354
Current income tax, net (108) 200 (387)
Other operating assets and liabilities of consolidated investment entities, net 6 1 (5)
Other, net 100 273 46
Net cash provided by (used in) operating activities 8,323 6,595 4,685
Available-for-Sale securities:      
Proceeds from sales 2,154 2,340 734
Maturities, sinking fund payments and calls 16,919 15,684 9,230
Purchases (19,504) (18,536) (19,694)
Proceeds from sales, maturities and repayments of mortgage loans 240 175 152
Funding of mortgage loans (713) (413) (284)
Proceeds from sales, maturities and collections of other investments 70 123 145
Purchase of other investments (51) (158) (116)
Purchase of investments by consolidated investment entities (1,431) (1,125) (427)
Proceeds from sales, maturities and repayments of investments by consolidated investment entities 988 1,117 643
Purchase of land, buildings, equipment and software (162) (176) (184)
Cash paid for written options with deferred premiums (50) (57) (59)
Cash received from written options with deferred premiums 20 22 43
Cash paid for deposit receivables (29) (33) (39)
Cash received for deposit receivables 427 592 774
Other, net (406) (106) (180)
Net cash provided by (used in) investing activities (1,528) (551) (9,262)
Investment certificates:      
Proceeds from additions 3,064 4,942 11,193
Maturities, withdrawals and cash surrenders (6,123) (7,212) (7,039)
Policyholder account balances:      
Deposits and other additions 1,293 1,470 1,476
Net transfers from (to) separate accounts (163) (176) (132)
Surrenders and other benefits (1,487) (1,765) (2,102)
Change in banking deposits, net 1,356 809 3,193
Cash paid for purchased options with deferred premiums (121) (148) (53)
Cash received for purchased options with deferred premiums 96 229 251
Issuance of long-term debt, net of issuance costs 741 0 1,335
Repayments of long-term debt (510) (561) (760)
Dividends paid to shareholders (596) (574) (550)
Repurchase of common shares (2,907) (2,448) (2,127)
Borrowings of consolidated investment entities 1,120 1,273 0
Repayments of debt by consolidated investment entities (922) (1,004) (275)
Other, net 2 0 1
Net cash provided by (used in) financing activities (5,157) (5,165) 4,411
Effect of exchange rate changes on cash 31 (10) 31
Net increase (decrease) in cash and cash equivalents, including amounts restricted 1,669 869 (135)
Cash and cash equivalents, including amounts restricted at beginning of period 9,489 8,620 8,755
Cash and cash equivalents, including amounts restricted at end of period 11,158 9,489 8,620
Supplemental Disclosures:      
Leased assets obtained in exchange for operating lease liabilities 50 39 67
Reconciliation of cash and cash equivalents, including amounts restricted:      
Restricted and segregated cash, cash equivalents and investments 1,055 1,444  
Less: Restricted and segregated investments 0 (477)  
Total cash and cash equivalents, including amounts restricted per consolidated statements of cash flows 11,158 9,489 8,620
Ameriprise Financial      
Supplemental Disclosures:      
Interest paid excluding consolidated investment entities 592 834 682
Reconciliation of cash and cash equivalents, including amounts restricted:      
Cash and cash equivalents 9,953 8,149  
Consolidated investment entities      
Supplemental Disclosures:      
Interest paid by consolidated investment entities 160 176 $ 177
Reconciliation of cash and cash equivalents, including amounts restricted:      
Cash and cash equivalents $ 150 $ 373